Shares of Polydex Pharmaceuticals Ltd. (OTCMKTS:POLXF – Get Free Report) crossed below its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $1.99 and traded as low as $1.9860. Polydex Pharmaceuticals shares last traded at $1.9860, with a volume of 2,000 shares traded.
Polydex Pharmaceuticals Stock Performance
The business has a 50-day moving average price of $1.99 and a 200-day moving average price of $1.99.
About Polydex Pharmaceuticals
Polydex Pharmaceuticals Ltd. is a development stage company, which engages in manufacturing of bulk pharmaceutical intermediates for the worldwide veterinary pharmaceutical industry, and the development, manufacturing, and marketing of biotechnology-based products for the human pharmaceutical market. The firm focuses on Dextran and derivative products, including Iron Dextran and Dextran Sulphate and other specialty chemicals. The company was founded by Thomas C. Usher on June 14, 1979 and is headquartered in Toronto, Canada.
Read More
- Five stocks we like better than Polydex Pharmaceuticals
- Why SK hynix Could Be the Best AI Chip Stock to Buy Now
- Seagate Technology Stock Surges as Earnings Beat Silences AI Doubters
- Alphabet Is Down 18% From Its High After a Stellar Quarter—Overdone, or More Downside Ahead?
- Why Bloom Energy May Be the Most Important AI Infrastructure Stock
Receive News & Ratings for Polydex Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Polydex Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
